Focus Therapy Areas: Oncology, Haematology, Immunology
Specialist Expertise: Cell & Gene Therapy, Pricing Strategy, Market Access and Personalised Medicine
Education: BSc Biochemistry, Cardiff University (Upper Second Class); MSc Drug Development Sciences, King’s College London (Distinction)
What is your focus at Eradigm?
To drive forward my passion for deciphering the true value of innovative healthcare products to provide strategic insights and solutions for impactful Market Access launch strategies. Working across a wide range of asset-level and Corporate Strategy projects, and Global Competitive Intelligence Monitoring, my aim is to deliver top-tier impactful recommendations and strategies to drive success for our clients.
Who do you work with?
I predominately work with global franchise teams, Market Access and commercial strategy leaders and senior leadership teams of top 15 biopharmaceutical and biotech companies.
What is your specialist expertise, and what types of projects do you work on?
My expertise lies within Cell & Gene Therapies and Market Access Excellence. My project portfolio has focused on several key areas, including cell & gene therapies (launch excellence, manufacturing and commercial strategy), pricing strategies (pre-launch and LOE), CI monitoring and Market Access Strategy & Access.
What did you do before Eradigm?
Before joining Eradigm, I gained Market Access experience as part of the Life Sciences Strategy & Access team at BearingPoint, where I contributed to several projects focusing on topics ranging from oncology to AI in healthcare. Prior to this, I presented my dissertation research on the Pharmacoeconomics and Market Access of Orphan Drugs as a finalist at the ISPOR 2019 conference.
What are your passions outside of work?
Outside of work, I enjoy long distance running, having completed numerous half and full marathons, and am a keen skier. I am also a passionate cook and love a wide range of music.